Journal of Korean Medical Science

Korean Acad Medical Sciences (대한의학회)
권호 표지
DOI QR코드

DOI QR Code

Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction

  • Published : 2010.10.30
⟨ Previous Next ⟩

Abstract

We sought to determine the prevalence of metabolic syndrome (MS) in patients with acute myocardial infarction and its effect on clinical outcomes. Employing data from the Korea Acute Myocardial Infarction Registry, a total of 1,990 patients suffered from acute STelevation myocardial infarction (STEMI) between November 2005 and December 2006 were categorized according to the National Cholesterol Education Program-Adult Treatment Panel III criteria of MS. Primary study outcomes included major adverse cardiac events (MACE) during one-year follow-up. Patients were grouped based on existence of MS: group I: MS (n=1,182, 777 men, 62.8${pm}$12.3 yr); group II: Non-MS (n=808, 675 men, 64.2${pm}$13.1 yr). Group I showed lower left ventricular ejection fraction (LVEF) (P=0.005). There were no differences between two groups in the coronary angiographic findings except for multivessel involvement (P=0.01). The incidence of in-hospital death was higher in group I than in group II (P=0.047), but the rates of composite MACE during one-year clinical follow-up showed no significant differences. Multivariate analysis showed that low LVEF, old age, MS, low high density lipoprotein cholesterol and multivessel involvement were associated with high in-hospital death rate. In conclusion, MS is an important predictor for in-hospital death in patients with STEMI.

Keywords

References

  1. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22. https://doi.org/10.1007/BF00403180
  2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
  3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16. https://doi.org/10.1001/jama.288.21.2709
  4. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-9. https://doi.org/10.1161/01.CIR.0000080897.52664.94
  5. Cha BS, Kim HJ. Metabolic syndrome and cardiovascular disease. Korean Circ J 2003; 33: 645-52. https://doi.org/10.4070/kcj.2003.33.8.645
  6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735-52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  7. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertension patients and control subjects. J Intern Med 1999; 245: 163-74. https://doi.org/10.1046/j.1365-2796.1999.00429.x
  8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9. https://doi.org/10.2337/diacare.24.4.683
  9. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93: 159-64. https://doi.org/10.1016/j.amjcard.2003.09.032
  10. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL; for the SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342-8. https://doi.org/10.1016/j.ehj.2003.12.007
  11. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M; 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex- CAPS). Am J Cardiol 2004; 93: 136-41. https://doi.org/10.1016/j.amjcard.2003.09.028
  12. Lee KH, Jeong MH, Ahn YK, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ; other Korea Acute Myocardial Infarction Registry Investigators. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008; 130: 227-34. https://doi.org/10.1016/j.ijcard.2007.08.044
  13. Sim DS, Jeong MH, Ahn YK, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2009; 103: 1333-8. https://doi.org/10.1016/j.amjcard.2009.01.339
  14. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004; 90: 99-106. https://doi.org/10.1136/heart.90.1.99
  15. Kini AS. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006; 24: 153-62. https://doi.org/10.1016/j.ccl.2006.04.002
  16. Manginas A, Gatzov P, Chasikidis C, Voudris V, Pavlides G, Cokkinos DV. Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Am J Cardiol 1999; 83: 1562-5. https://doi.org/10.1016/S0002-9149(99)00149-6
  17. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007; 115: 1806-11. https://doi.org/10.1161/CIRCULATIONAHA.106.658336
  18. Gale EA. Should we dump the metabolic syndrome? Yes. BMJ 2008; 336: 640. https://doi.org/10.1136/bmj.39477.500197.AD
  19. Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSIPrevenzione Investigators. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005; 46: 277-83. https://doi.org/10.1016/j.jacc.2005.03.062
  20. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, Beer JC, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Vergès B, Cottin Y; Observatoire des Infarctus de Cote-d'Or Survey Working Group. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192-8. https://doi.org/10.1001/archinte.165.10.1192
  21. Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A; HIFMECH Study Group. Low grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004; 53: 852-7. https://doi.org/10.1016/j.metabol.2004.02.004
  22. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-7. https://doi.org/10.1016/j.ehj.2004.09.021
  23. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109: 551-6. https://doi.org/10.1161/01.CIR.0000112379.88385.67
  24. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403. https://doi.org/10.1056/NEJMoa012512
  25. Wannamethee SG, Shaper AG, Morris RW, Whincup PH. Measures of adiposity in the identification of metabolic abnormalities in elderly men. Am J Clin Nutr 2005; 81: 1313-21. https://doi.org/10.1093/ajcn/81.6.1313
  26. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74. https://doi.org/10.1056/NEJMoa031049
  27. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 331: 158-61.
  28. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004; 109: 706-13. https://doi.org/10.1161/01.CIR.0000115514.44135.A8

Cited by

  1. Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Anal vol.41, pp.12, 2011, https://doi.org/10.4070/kcj.2011.41.12.718
  2. Incidence of Metabolic Syndrome and Relative Importance of Five Components as a Predictor of Metabolic Syndrome: 5-Year Follow-up Study in Korea vol.28, pp.12, 2010, https://doi.org/10.3346/jkms.2013.28.12.1768
  3. One-Year Clinical Outcomes among Patients with Metabolic Syndrome and Acute Myocardial Infarction vol.43, pp.8, 2010, https://doi.org/10.4070/kcj.2013.43.8.519
  4. Clinical Impact of High Triglycerides and Central Obesity in Patients with Acute Myocardial Infarction who Underwent Percutaneous Coronary Intervention vol.86, pp.2, 2014, https://doi.org/10.3904/kjm.2014.86.2.169
  5. The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry vol.29, pp.6, 2010, https://doi.org/10.3904/kjim.2014.29.6.703
  6. A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital vol.10, pp.None, 2010, https://doi.org/10.2147/cia.s70372
  7. 농촌지역 주민의 대사증후군 발생률과 위험요인 vol.16, pp.6, 2015, https://doi.org/10.5762/kais.2015.16.6.3934
  8. Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease vol.15, pp.None, 2016, https://doi.org/10.1186/s12933-016-0466-6
  9. The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction vol.13, pp.4, 2010, https://doi.org/10.5114/aoms.2016.59703
  10. THE INFLUENCE OF METABOLIC SYNDROME ON T HE QUALITY OF LIFE IN PATIENTS WITH ACU TE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION vol.57, pp.4, 2010, https://doi.org/10.5633/amm.2018.0410
  11. Long-Term Prognosis for Patients with Metabolic Syndrome after Recanalization Therapy for Stroke vol.18, pp.9, 2010, https://doi.org/10.1089/met.2020.0053